IL64256A - 2,4-diamino-5-(substituted methyl)-pyrimidines,their preparation and pharmaceutical compositions containing them - Google Patents
2,4-diamino-5-(substituted methyl)-pyrimidines,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL64256A IL64256A IL64256A IL6425681A IL64256A IL 64256 A IL64256 A IL 64256A IL 64256 A IL64256 A IL 64256A IL 6425681 A IL6425681 A IL 6425681A IL 64256 A IL64256 A IL 64256A
- Authority
- IL
- Israel
- Prior art keywords
- pyrimidines
- diamino
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
- C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL7563481A IL75634A (en) | 1980-11-11 | 1981-11-10 | 2,3-disubstituted propanenitrile and cyanopropanoic acid ester derivatives |
| IL7563581A IL75635A (en) | 1980-11-11 | 1981-11-10 | 5-(substituted methyl)-halopyrimidines |
| IL75634A IL75634A0 (en) | 1980-11-11 | 1985-06-26 | Substituted acrylonitrile and cyanopropenoate derivatives |
| IL75635A IL75635A0 (en) | 1980-11-11 | 1985-06-26 | Substituted pyrimidine derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8036135 | 1980-11-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL64256A0 IL64256A0 (en) | 1982-02-28 |
| IL64256A true IL64256A (en) | 1988-01-31 |
Family
ID=10517217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL64256A IL64256A (en) | 1980-11-11 | 1981-11-10 | 2,4-diamino-5-(substituted methyl)-pyrimidines,their preparation and pharmaceutical compositions containing them |
Country Status (35)
| Country | Link |
|---|---|
| US (4) | US4438267A (cs) |
| EP (1) | EP0051879B1 (cs) |
| JP (1) | JPS57114581A (cs) |
| KR (1) | KR880001736B1 (cs) |
| AR (1) | AR245447A1 (cs) |
| AU (1) | AU549449B2 (cs) |
| CA (1) | CA1186310A (cs) |
| CS (1) | CS273153B2 (cs) |
| CY (1) | CY1419A (cs) |
| DD (1) | DD201896A5 (cs) |
| DE (1) | DE3173752D1 (cs) |
| DK (1) | DK172884B1 (cs) |
| EG (1) | EG16107A (cs) |
| ES (5) | ES8307759A1 (cs) |
| FI (1) | FI76333C (cs) |
| GB (1) | GB2087881B (cs) |
| GR (1) | GR81317B (cs) |
| HK (1) | HK23388A (cs) |
| HU (1) | HU188762B (cs) |
| IE (1) | IE52128B1 (cs) |
| IL (1) | IL64256A (cs) |
| IT (1) | IT1210589B (cs) |
| MC (1) | MC1418A1 (cs) |
| MY (1) | MY8600678A (cs) |
| NO (2) | NO160137C (cs) |
| NZ (1) | NZ198932A (cs) |
| PH (2) | PH22654A (cs) |
| PL (4) | PL139523B1 (cs) |
| PT (1) | PT73960B (cs) |
| RU (1) | RU1819264C (cs) |
| SG (1) | SG62686G (cs) |
| SU (4) | SU1424732A3 (cs) |
| YU (5) | YU42444B (cs) |
| ZA (1) | ZA817780B (cs) |
| ZM (1) | ZM9481A1 (cs) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4438267A (en) * | 1980-11-11 | 1984-03-20 | Daluge Susan M | Monoheteroring compounds and their use |
| US4590271A (en) * | 1982-05-01 | 1986-05-20 | Burroughs Wellcome Co. | 2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials |
| ZA833067B (en) * | 1982-05-01 | 1984-12-24 | Wellcome Found | Antibacterial compounds |
| DK190983A (da) * | 1982-05-01 | 1983-11-02 | Wellcome Found | 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor |
| US4587341A (en) * | 1982-05-07 | 1986-05-06 | Burroughs Wellcome Co. | 2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials |
| CA1244028A (en) * | 1983-04-14 | 1988-11-01 | Hans Maag | Pyrimidine derivatives |
| GB8603962D0 (en) * | 1986-02-18 | 1986-03-26 | Wellcome Found | Chemical compositions |
| GB8603964D0 (en) * | 1986-02-18 | 1986-03-26 | Cooper Animal Health Ltd | Compositions |
| LU86703A1 (fr) * | 1986-12-08 | 1988-07-14 | Oreal | Composition cosmetique photostable contenant un filtre uv-a et un filtre uv-b,son utilisation pour la protection de la peau contre les rayons uv et procede de stabilisation du filtre uv-a par le filtre uv-b |
| FI895821A7 (fi) * | 1988-12-07 | 1990-06-08 | The Wellcome Foundation Ltd | Farmaseuttisesti aktivisia CNS-yhdisteitä |
| GB8903978D0 (en) * | 1989-02-22 | 1989-04-05 | Coopers Animal Health | Chemical compositions |
| GB9000241D0 (en) * | 1990-01-05 | 1990-03-07 | Coopers Animal Health | Pharmaceutical use |
| RU95113597A (ru) * | 1992-12-02 | 1997-06-10 | ФМК Корпорейшн (US) | Инсектицидная композиция, способы борьбы с насекомыми |
| KR100224135B1 (ko) * | 1993-01-28 | 1999-10-15 | 다께다 구니오 | 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도 |
| US5707996A (en) * | 1995-11-06 | 1998-01-13 | Macleod Pharmaceuticals, Inc. | Pharmaceutical solution and methods for preparation thereof |
| EP1149834A1 (en) * | 1995-12-04 | 2001-10-31 | F. Hoffmann-La Roche Ag | Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial |
| RU2141322C1 (ru) * | 1997-08-12 | 1999-11-20 | Голощапов Николай Михайлович | Иммуномодулятор с антимикобактериальной активностью "изофон", способ его получения и применения |
| GB0016877D0 (en) * | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Chemical compounds |
| WO2002010156A1 (en) * | 2000-07-29 | 2002-02-07 | Arpida Ag | Benzofuran derivatives and their use as antibacterial agents |
| US7678805B2 (en) | 2001-06-29 | 2010-03-16 | Ab Science | Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD) |
| JP2005500041A (ja) * | 2001-06-29 | 2005-01-06 | アブ サイエンス | 強力で選択的かつ非毒性のc−kit阻害剤 |
| WO2003002108A2 (en) * | 2001-06-29 | 2003-01-09 | Ab Science | Use of tyrosine kinase inhibitors for treating inflammatory diseases |
| CA2452371A1 (en) * | 2001-06-29 | 2003-01-09 | Ab Science | Use of tyrosine kinase inhibitors for treating allergic diseases |
| CA2461182A1 (en) * | 2001-09-20 | 2003-05-01 | Ab Science | Use of tyrosine kinase inhibitors for promoting hair growth |
| JP2005507916A (ja) * | 2001-09-20 | 2005-03-24 | アブ サイエンス | 細菌感染症を治療するための、強力で選択的かつ非毒性のc−kit阻害剤の使用方法 |
| US20040242601A1 (en) * | 2001-09-20 | 2004-12-02 | Alain Moussy | Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
| CA2531757A1 (en) | 2003-07-11 | 2005-01-20 | Arpida Ag | Benzofuran derivatives and their use in the treatment of microbial infections |
| CN101115746A (zh) * | 2005-02-18 | 2008-01-30 | 阿皮德公开股份有限公司 | 用于制备苯并呋喃的新方法 |
| CA2619898C (en) * | 2005-09-01 | 2014-03-18 | F. Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| US20100029689A1 (en) * | 2008-07-02 | 2010-02-04 | Memory Pharmaceuticals Corporation | Phosphodiesterase 4 inhibitors |
| CA2778931A1 (en) * | 2009-06-12 | 2010-12-16 | Marianne Allard | Guanine riboswitch binding compounds and their use as antibiotics |
| CN102649786B (zh) * | 2011-02-28 | 2014-08-27 | 郑州福源动物药业有限公司 | 一种2,4-二氨基-5-(8-二甲氨基-7-甲基-5-喹啉基甲基)-2,4-(1h,3h)嘧啶的制备方法 |
| CN103755684B (zh) * | 2014-02-10 | 2015-09-09 | 青岛蔚蓝生物股份有限公司 | 一种巴喹普林的制备方法 |
| US20220332714A1 (en) * | 2019-06-06 | 2022-10-20 | Beijing Tide Pharmaceutical Co., Ltd. | P2x3 and/or p2x2/3 receptor antagonist, pharmaceutical composition containing same, and use thereof |
| CN110818694B (zh) * | 2019-11-18 | 2023-04-21 | 上海医药工业研究院有限公司 | 艾拉普林中间体及其应用 |
| WO2022217295A1 (en) * | 2021-04-09 | 2022-10-13 | The Trustees Of The University Of Pennsylvania | Control of protein expression with tmp-protac compounds |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3049544A (en) * | 1962-08-14 | Method for the preparation of | ||
| DE1303727B (de) | 1959-09-03 | 1976-02-05 | Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London | Alpha-Arylidensubstituierte Propioni-Irile |
| US3956327A (en) * | 1969-03-06 | 1976-05-11 | Burroughs Wellcome Co. | Method of preparing 2,4-diamino-5-benzyl pyrimidines |
| BE792096A (fr) * | 1971-12-01 | 1973-05-30 | Hoffmann La Roche | Nouvelles benzylpyrimidines |
| GB1468374A (en) | 1974-03-06 | 1977-03-23 | Wellcome Found | Process for preparing a pyrimidine derivative |
| US4039543A (en) | 1974-12-24 | 1977-08-02 | Hoffmann-La Roche Inc. | Benzylpyrimidines |
| GB1582245A (en) * | 1976-06-09 | 1981-01-07 | Wellcome Found | Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives |
| DE2730467A1 (de) * | 1977-07-06 | 1979-01-18 | Basf Ag | Benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| US4258045A (en) * | 1979-11-30 | 1981-03-24 | Merck & Co., Inc. | Inhibitor of dihydrofolate reductase |
| US4438267A (en) * | 1980-11-11 | 1984-03-20 | Daluge Susan M | Monoheteroring compounds and their use |
-
1981
- 1981-11-09 US US06/319,644 patent/US4438267A/en not_active Expired - Lifetime
- 1981-11-10 DK DK198104966A patent/DK172884B1/da active Protection Beyond IP Right Term
- 1981-11-10 SU SU813358051A patent/SU1424732A3/ru active
- 1981-11-10 YU YU2663/81A patent/YU42444B/xx unknown
- 1981-11-10 NO NO813804A patent/NO160137C/no not_active IP Right Cessation
- 1981-11-10 DD DD81234745A patent/DD201896A5/de not_active IP Right Cessation
- 1981-11-10 CA CA000389807A patent/CA1186310A/en not_active Expired
- 1981-11-10 PL PL1981233754A patent/PL139523B1/pl unknown
- 1981-11-10 IT IT8149676A patent/IT1210589B/it active
- 1981-11-10 PT PT73960A patent/PT73960B/pt unknown
- 1981-11-10 AU AU77334/81A patent/AU549449B2/en not_active Expired
- 1981-11-10 ES ES506969A patent/ES8307759A1/es not_active Expired
- 1981-11-10 MC MC811560A patent/MC1418A1/fr unknown
- 1981-11-10 JP JP56180271A patent/JPS57114581A/ja active Granted
- 1981-11-10 IL IL64256A patent/IL64256A/xx not_active IP Right Cessation
- 1981-11-10 CS CS825781A patent/CS273153B2/cs unknown
- 1981-11-10 KR KR1019810004348A patent/KR880001736B1/ko not_active Expired
- 1981-11-10 FI FI813546A patent/FI76333C/fi not_active IP Right Cessation
- 1981-11-10 EG EG653/81A patent/EG16107A/xx active
- 1981-11-10 PL PL1981239278A patent/PL139827B1/pl unknown
- 1981-11-10 GB GB8133833A patent/GB2087881B/en not_active Expired
- 1981-11-10 NZ NZ198932A patent/NZ198932A/en unknown
- 1981-11-10 IE IE2631/81A patent/IE52128B1/en not_active IP Right Cessation
- 1981-11-10 GR GR66482A patent/GR81317B/el unknown
- 1981-11-10 HU HU813359A patent/HU188762B/hu unknown
- 1981-11-10 ZA ZA817780A patent/ZA817780B/xx unknown
- 1981-11-10 PL PL1981239279A patent/PL139427B1/pl unknown
- 1981-11-10 PL PL1981239280A patent/PL139828B1/pl unknown
- 1981-11-11 EP EP81109631A patent/EP0051879B1/en not_active Expired
- 1981-11-11 DE DE8181109631T patent/DE3173752D1/de not_active Expired
- 1981-11-11 ZM ZM94/81A patent/ZM9481A1/xx unknown
- 1981-11-11 CY CY141981A patent/CY1419A/xx unknown
-
1983
- 1983-01-27 SU SU833543245A patent/SU1318148A3/ru active
- 1983-01-31 SU SU833547444A patent/SU1306473A3/ru active
- 1983-04-02 ES ES521202A patent/ES8405378A1/es not_active Expired
- 1983-04-02 ES ES521204A patent/ES8405380A1/es not_active Expired
- 1983-04-02 ES ES521203A patent/ES521203A0/es active Granted
- 1983-04-02 ES ES521201A patent/ES8405377A1/es not_active Expired
- 1983-09-07 PH PH29502A patent/PH22654A/en unknown
- 1983-09-07 PH PH29503A patent/PH25053A/en unknown
- 1983-10-03 YU YU01981/83A patent/YU198183A/xx unknown
- 1983-10-03 YU YU1983/83A patent/YU43551B/xx unknown
- 1983-10-03 YU YU01982/83A patent/YU198283A/xx unknown
- 1983-10-31 US US06/546,850 patent/US4587342A/en not_active Expired - Lifetime
- 1983-12-30 US US06/567,248 patent/US4603136A/en not_active Expired - Lifetime
-
1986
- 1986-02-02 RU SU863552053A patent/RU1819264C/ru active
- 1986-03-12 US US06/839,463 patent/US4761475A/en not_active Expired - Lifetime
- 1986-07-17 SG SG626/86A patent/SG62686G/en unknown
- 1986-12-30 MY MY678/86A patent/MY8600678A/xx unknown
-
1987
- 1987-01-14 SU SU874028793A patent/SU1535379A3/ru active
-
1988
- 1988-03-30 HK HK233/88A patent/HK23388A/en not_active IP Right Cessation
- 1988-06-17 AR AR88311165A patent/AR245447A1/es active
- 1988-07-26 YU YU144288A patent/YU46697B/sh unknown
-
1994
- 1994-12-29 NO NO1994029C patent/NO1994029I1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL64256A (en) | 2,4-diamino-5-(substituted methyl)-pyrimidines,their preparation and pharmaceutical compositions containing them | |
| IL63940A0 (en) | Substituted imino-diacids,their preparation and pharmaceutical compositions containing them | |
| IL66099A0 (en) | N-aryl-piperazinealkanamides,their preparation and pharmaceutical compositions containing them | |
| IL65814A (en) | 3-phenylalkylaminoalkyl-3-benzazepine and 1,3-benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL65257A0 (en) | Arylcyclo-butanealkylamine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL64504A (en) | Aminoalkoxyphenyl substituted quinazolinones and pyridopyrimidinones,their preparation and pharmaceutical compositions containing them | |
| IL65803A (en) | Cyclobutene-dione derivatives,their preparation and pharmaceutical compositions containing them | |
| IL64665A (en) | 4-amino-6,7-dimethoxy-2-piperazino-quinazoline derivatives,their preparation and pharmaceutical compositions containing them | |
| IL75147A0 (en) | Pyrimidine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL60086A0 (en) | Pyrimidine compounds,their preparation and pharmaceutical compositions containing them | |
| IL65076A (en) | 3,4-dihydro-5h-2,3-benzo-diazepine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL64777A0 (en) | 3-aminopropoxyaryl derivatives,their preparation and pharmaceutical compositions containing them | |
| IL66683A0 (en) | Benzo-heterocycles,their preparation and pharmaceutical compositions containing them | |
| IL63368A0 (en) | 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines,their preparation and pharmaceutical compositions containing them | |
| IL65327A0 (en) | Acylquinolinone derivatives,their preparation and pharmaceutical compositions containing them | |
| ZA816844B (en) | Substituted iminodiacids,their preparation and pharmaceutical compositions containing them | |
| IL57081A0 (en) | Substituted 1,3-diarly-2-imino-imidazolidines and hexahydropyrimidines their preparation and pharmaceutical compositions containing them | |
| IL66238A0 (en) | Benzothiazolesulfonamide derivatives,their preparation and pharmaceutical compositions containing them | |
| IL65160A (en) | Substituted heteroaromatic guanidine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL63773A (en) | Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide,its preparation and pharmaceutical compositions containing it | |
| IL65422A (en) | 2-piperazino-pyrimidine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL64563A0 (en) | 3,4-bis-substituted 1,2,5-oxidiazole 2-oxides,their preparation and pharmaceutical compositions containing them | |
| IL64252A (en) | 3,3-dimethyl-indolin-2-ones,their preparation and pharmaceutical compositions containing them | |
| IL69407A0 (en) | 2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them | |
| DE3366170D1 (en) | Pyrimidone compounds, their preparation, and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| EXP | Patent expired |